GeneDx Holdings WGS Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$77.81M— | -$21.02M— | —— | —— | —— | ||
| $26.36M+17.7% | $25.22M+14.9% | $23.9M+6.3% | $23.36M-7.4% | $22.38M-26.2% | ||
| $37.18M+174% | $32.16M+252% | $25.23M+369% | $18.28M+740% | $13.57M+1,745% | ||
| —— | —— | —— | —— | $186K+122% | ||
| —— | —— | —— | —— | $0-100% | ||
| $30.23M— | $36.23M— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| $3.44M+8.9% | $3.16M-3.8% | $3.03M+320% | $2.94M+281% | $3.16M+235% | ||
| —— | —— | —— | —— | —— | ||
| -$6.22M-227% | $36.37M+228% | $33.19M+160% | $13.02M+114% | -$1.9M+98.7% | ||
| $19.34M+73.0% | $19.02M+246% | $17.72M+268% | $12.19M+185% | $11.18M+96.3% | ||
| $2.94M— | $2.06M— | $3K— | —— | —— | ||
| -$69.36M-71.8% | -$61.52M-104% | -$50.96M-47.8% | -$54.03M-0.3% | -$40.38M+4.8% | ||
| —— | —— | —— | —— | —— | ||
| $2.5M+575% | $2.02M+413% | $1.13M+324% | $1.03M— | $370K— | ||
| $2.34M-18.8% | $2.45M-10.2% | $3.3M+11.4% | $2.9M-13.8% | $2.88M-4.5% | ||
| $72.9M+25.0% | $48.03M+8.7% | $55.86M-7.3% | $59.06M+27.6% | $58.32M+7.9% | ||
| -$5.78M— | $19.79M— | —— | —— | —— | ||
| $6.56M+4.8% | $6.41M-4.0% | $6.48M-6.9% | $5.85M-4.5% | $6.26M+39.8% | ||
| $1.82M+69.9% | $1.28M+9.3% | $1.3M+8.3% | $1.53M+50.1% | $1.07M-35.4% | ||
| —— | —— | —— | —— | $0-100% | ||
| —— | —— | —— | —— | —— | ||
| $38.54M-21.6% | $43.97M+7.1% | $50.06M+92.1% | $59.05M+123% | $49.14M+108% | ||
| $2.94M— | $2.06M— | $3K— | —— | —— | ||
| $2.34M-18.8% | $2.45M-10.2% | $3.3M+11.4% | $2.9M-13.8% | $2.88M-4.5% | ||
| $129.94M+115% | $46.83M+0.7% | $57.6M— | $60.39M— | $60.39M— | ||
| —— | —— | —— | $7.86M— | $4.77M— | ||
| —— | —— | $4.3M-60.6% | $1.78M-81.1% | $8.37M+466% | ||
| —— | —— | —— | —— | $0-100% | ||
| —— | $0— | $0-100% | $0-100% | $0-100% | ||
| —— | —— | $15.47M+126% | $830K+101% | -$13.08M+91.1% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does GeneDx Holdings generate?
- GeneDx Holdings (WGS) generated -$6.2M in operating cash flow over the trailing twelve months.
- What is GeneDx Holdings's free cash flow?
- After $19.3M of capital expenditures, GeneDx Holdings's free cash flow was -$17.2M over the trailing twelve months, up 49.5% year over year.
- Where does GeneDx Holdings's cash flow data come from?
- Every line is extracted from GeneDx Holdings's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
